Published in Ann Rheum Dis on January 01, 1993
Advances in interleukin 2 receptor targeted treatment. Ann Rheum Dis (2000) 1.26
Effect of cyclosporin A on interleukin-6 and soluble interleukin-2 receptor in patients with rheumatoid arthritis. Ann Rheum Dis (1995) 0.81
Serum interleukin-2 receptor for the early diagnosis of rheumatoid arthritis. Clin Rheumatol (1998) 0.81
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Interleukin-2: inception, impact, and implications. Science (1988) 8.19
The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med (1990) 2.34
Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J Exp Med (1983) 1.57
Serum interleukin-2-receptor in rheumatoid arthritis: a prognostic indicator of disease activity? J Autoimmun (1988) 1.38
Immunohistological features in the synovium obtained from clinically uninvolved knee joints of patients with rheumatoid arthritis. Br J Rheumatol (1989) 1.37
Inhibition of human endothelial cell proliferation by gold compounds. J Clin Invest (1987) 1.22
Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis. Arthritis Rheum (1988) 1.15
The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis. Arthritis Rheum (1990) 1.11
Changes in lymphocyte infiltration of the synovial membrane and the clinical course of rheumatoid arthritis. Arthritis Rheum (1989) 1.09
Value of joint scintigraphy in the prediction of erosiveness in early rheumatoid arthritis. Ann Rheum Dis (1988) 1.05
High-affinity interleukin-2 receptors on blood lymphocytes are decreased during active rheumatoid arthritis. Arthritis Rheum (1988) 0.89
Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis. Ann Rheum Dis (1992) 0.86
Meta-analysis of theory-of-mind development: the truth about false belief. Child Dev (2001) 11.06
Continuous proliferation of murine antigen-specific helper T lymphocytes in culture. J Exp Med (1979) 7.20
Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines. J Exp Med (1979) 5.22
Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic respones to lipopolysaccharides. J Exp Med (1974) 4.48
Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J Exp Med (1980) 4.32
How to ensure that guidelines are effective. BMJ (1995) 4.31
Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA (2000) 3.87
ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev (1999) 3.45
Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines. J Immunol (1980) 3.28
Generic inhalers for asthma. BMJ (1994) 3.09
ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J Cell Sci (1998) 2.83
Molecular and quantitative analysis of helper T cell-replacing factors on the induction of antigen-sensitive B and T lymphocytes. J Immunol (1979) 2.79
Immune response to Campylobacter pyloridis in patients with peptic ulceration. Lancet (1985) 2.64
Young people, alcohol, and designer drinks: quantitative and qualitative study. BMJ (1997) 2.64
Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J (Clin Res Ed) (1983) 2.63
HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol (2000) 2.60
Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays. J Exp Med (1983) 2.56
The genetic mapping of a defective LPS response gene in C3H/HeJ mice. J Immunol (1978) 2.43
Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet (1991) 2.37
The use of bacterial lipopolysaccharides to show that two signals are required for the induction of antibody synthesis. J Exp Med (1973) 2.30
Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin. Proc Natl Acad Sci U S A (1993) 2.28
Interleukin 2: a class of T cell growth factors. Immunol Rev (1980) 2.21
Performance of an established system of first responder out-of-hospital defibrillation. The results of the second year of the Heartstart Scotland Project in the 'Utstein Style'. Resuscitation (1993) 2.17
An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J Hosp Infect (1998) 2.10
Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis (1993) 2.05
External fixation versus conservative treatment for distal radial fractures in adults. Cochrane Database Syst Rev (2007) 2.03
Cutting waiting lists. BMJ (1991) 2.02
Illiteracy in rheumatoid arthritis patients as determined by the Rapid Estimate of Adult Literacy in Medicine (REALM) score. Rheumatology (Oxford) (2002) 2.00
The purification and quantitation of helper T cell-replacing factors secreted by murine spleen cells activated by concanavalin A. J Immunol (1979) 1.95
The role of humoral factors in the initiation of in vitro primary immune responses. II. Effects of lymphocyte mitogens. J Immunol (1973) 1.90
Research Governance: a barrier to ethical research? QJM (2004) 1.89
Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth: the Women and Infants Transmission Study (WITS). J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.88
Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.87
Percutaneous pinning for treating distal radial fractures in adults. Cochrane Database Syst Rev (2007) 1.82
Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas. J Immunol (1980) 1.79
A survey of zoonotic pathogens carried by Norway rats in Baltimore, Maryland, USA. Epidemiol Infect (2007) 1.73
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol (1996) 1.73
Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis (1984) 1.69
Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial. Ann Rheum Dis (2004) 1.69
Enteroaggregative Escherichia coli heat-stable enterotoxin is not restricted to enteroaggregative E. coli. J Infect Dis (1996) 1.69
The response of recombinant inbred strains of mice to bacterial lipopolysaccharides. J Immunol (1977) 1.64
Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus. Br Med J (Clin Res Ed) (1986) 1.64
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63
c-myc oncogene expression in colorectal cancer. Cancer (1987) 1.60
Analysis of Photosynthetic Antenna Function in a Mutant of Arabidopsis thaliana (L.) Lacking trans-Hexadecenoic Acid. Plant Physiol (1985) 1.60
Efficacy of out of hospital defibrillation by ambulance technicians using automated external defibrillators. The Heartstart Scotland Project. Resuscitation (1992) 1.60
Helper T cell-replacing factors secreted by thymus-derived cells and macrophages: cellular requirements for B cell activation and synergistic properties. J Immunol (1979) 1.59
Anesthesia for intranasal surgery: a comparison between tracheal intubation and the flexible reinforced laryngeal mask airway. Anesth Analg (1999) 1.59
Effectiveness of antismoking telephone helpline: follow up survey. BMJ (1997) 1.58
Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs. Am J Gastroenterol (1991) 1.57
Surgical interventions for treating distal radial fractures in adults. Cochrane Database Syst Rev (2003) 1.57
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed) (1986) 1.55
The role of humoral factors in the initiation of in vitro primary immune responses. 3. Characterization of factors that replace thymus-derived cells. J Immunol (1973) 1.55
Misoprostol in patients taking non-steroidal anti-inflammatory drugs. BMJ (1995) 1.54
Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. Euro Surveill (2012) 1.51
Which component of sulphasalazine is active in rheumatoid arthritis? Br Med J (Clin Res Ed) (1985) 1.51
A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question? Ann Rheum Dis (1985) 1.50
Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med (1998) 1.50
Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis (1985) 1.49
Toward a caring curriculum: a new pedagogy for nursing. NLN Publ (1989) 1.49
Gastroparesis with multiple sclerosis. Mult Scler (2006) 1.48
The influence of intracellular levels of cyclic nucleotides on cell proliferation and the induction of antibody synthesis. J Exp Med (1975) 1.48
Detection of the c-myc oncogene product in colonic polyps and carcinomas. Br J Cancer (1986) 1.47
Interleukin-2 dependent culture of cytolytic T cell lines. Immunol Rev (1981) 1.46
On nursing theories and evidence. J Nurs Scholarsh (2001) 1.46
Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. Br J Rheumatol (1987) 1.45
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Surgical interventions for treating distal radial fractures in adults. Cochrane Database Syst Rev (2001) 1.44
Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Q J Med (1986) 1.44
Antineutrophil cytoplasmic antibody titres in patients with recent infection. Br J Rheumatol (1993) 1.42
The 'natural' history of active rheumatoid arthritis over 3-6 months--an analysis of patients enrolled into trials of potential disease-modifying anti-rheumatic drugs, and treated with placebo. Br J Rheumatol (1993) 1.42
Personal experience with ultrasound-assisted lipoplasty: a pilot study comparing ultrasound-assisted lipoplasty with traditional lipoplasty. Plast Reconstr Surg (1998) 1.41
A case of orbital myositis associated with rheumatoid arthritis. Ann Rheum Dis (2002) 1.40
Leukemia viruses associated with mouse myeloma cells. Proc Natl Acad Sci U S A (1970) 1.40
Reflections on the recommendations of the EWMA Patient Outcome Group document. J Wound Care (2010) 1.39
Pneumocystis carinii infection complicating cytotoxic therapy in two patients with lymphopenia, but a normal total white cell count. Br J Rheumatol (1992) 1.39
Cumulation characteristics of cisatracurium and rocuronium during continuous infusion. Can J Anaesth (2000) 1.39
Availability of condoms in district general hospitals. BMJ (1990) 1.39
Cyclic nucleotides as intracellular mediators of the expression of antigen-sensitive cells. Nature (1973) 1.39
[Not Available]. Praxis (Bern 1994) (2011) 1.38
Predictive value of interleukin 1 gene polymorphisms for surgery. Ann Rheum Dis (2000) 1.38
Alcohol use among migrant laborers in western New York. J Stud Alcohol (1985) 1.37
The integrated implementation of two end-of-life care tools in nursing care homes in the UK: an in-depth evaluation. Palliat Med (2010) 1.35
Genetic control of responses to Trypanosoma cruzi in mice: multiple genes influencing parasitemia and survival. Infect Immun (1982) 1.34
Immunologic properties of bacterial lipopolysaccharide (LPS). III. Genetic linkage between the in vitro mitogenic and in vivo adjuvant properties of LPS. J Exp Med (1976) 1.34
The use of the Internet as a resource for health information among patients attending a rheumatology clinic. Rheumatology (Oxford) (2002) 1.33
Co-ordinated multidisciplinary approaches for inpatient rehabilitation of older patients with proximal femoral fractures. Cochrane Database Syst Rev (2001) 1.33
Isolation of an Hfr donor of Pseudomonas aeruginosa PAO by insertion of the plasmid RP1 into the tryptophan synthase gene. Mol Gen Genet (1981) 1.32
Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1. Br J Pharmacol (2008) 1.32
Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol (1985) 1.30
Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev (2003) 1.30
Sulphasalazine: a 'new' antirheumatic drug. Br J Rheumatol (1984) 1.30